Funding for this research was provided by:
KWF Kankerbestrijding (KUN 2012–5545)
Received: 11 November 2018
Accepted: 15 April 2019
First Online: 16 May 2019
Ethics approval and consent to participate
: The RCT was approved by an ethical board (CMO Arnhem-Nijmegen). Written informed consent was obtained from all eligible participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.